Haematologica (Nov 2018)
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
- Feng-Ming Tien,
- Hsin-An Hou,
- Jih-Luh Tang,
- Yuan-Yeh Kuo,
- Chien-Yuan Chen,
- Cheng-Hong Tsai,
- Ming Yao,
- Chien-Ting Lin,
- Chi-Cheng Li,
- Shang-Yi Huang,
- Bor-Sheng Ko,
- Szu-Chun Hsu,
- Shang-Ju Wu,
- Jia-Hau Liu,
- Sheng Chieh Chou,
- Woei Tsay,
- Mei-Hsuan Tseng,
- Ming-Chih Liu,
- Chia-Wen Liu,
- Liang-In Lin,
- Wen-Chien Chou,
- Hwei-Fang Tien
Affiliations
- Feng-Ming Tien
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital;Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University;Tai-Cheng Stem Cell Therapy Center, National Taiwan University
- Hsin-An Hou
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Jih-Luh Tang
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital;Tai-Cheng Stem Cell Therapy Center, National Taiwan University
- Yuan-Yeh Kuo
- Graduate Institute of Oncology, College of Medicine, National Taiwan University
- Chien-Yuan Chen
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Cheng-Hong Tsai
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital;Tai-Cheng Stem Cell Therapy Center, National Taiwan University
- Ming Yao
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Chien-Ting Lin
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital;Tai-Cheng Stem Cell Therapy Center, National Taiwan University
- Chi-Cheng Li
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital;Tai-Cheng Stem Cell Therapy Center, National Taiwan University
- Shang-Yi Huang
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Bor-Sheng Ko
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Szu-Chun Hsu
- Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
- Shang-Ju Wu
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Jia-Hau Liu
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital;Tai-Cheng Stem Cell Therapy Center, National Taiwan University
- Sheng Chieh Chou
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Woei Tsay
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Mei-Hsuan Tseng
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- Ming-Chih Liu
- Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
- Chia-Wen Liu
- Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
- Liang-In Lin
- Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan
- Wen-Chien Chou
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital;Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
- Hwei-Fang Tien
- Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital
- DOI
- https://doi.org/10.3324/haematol.2018.189043
- Journal volume & issue
-
Vol. 103,
no. 11
Abstract
No abstracts available.